Advertisement
Advertisement
NDRA
ENDRA Life Sciences Inc. Common Stock
4.86
USDSponsored
-0.37
-7.07%
Jul 24, 15:56 UTC -4
Closed
After-Market
5.02
+0.16
+3.29%
NDRA Earnings Reports
Positive Surprise Ratio
NDRA beat 18 of 29 last estimates.
62%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.85
Implied change from Q1 26 (Revenue/ EPS)
--
/-52.78%
Implied change from Q2 25 (Revenue/ EPS)
--
/-50.29%
ENDRA Life Sciences Inc. Common Stock earnings per share and revenue
On May 15, 2026, NDRA reported earnings of -1.80 USD per share (EPS) for Q1 26, missing the estimate of -1.25 USD, resulting in a -43.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.13% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.85 USD, with revenue projected to reach -- USD, implying an decrease of -52.78% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.53%
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.27%
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
FAQ
What were ENDRA Life Sciences Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, ENDRA Life Sciences Inc. Common Stock reported EPS of -$1.80, missing estimates by -43.47%, and revenue of $0.00, 0% as expectations.
How did the market react to ENDRA Life Sciences Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 7.13%, changed from $5.05 before the earnings release to $5.41 the day after.
When is ENDRA Life Sciences Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for ENDRA Life Sciences Inc. Common Stock's next earnings report?
Based on 3
analysts, ENDRA Life Sciences Inc. Common Stock is expected to report EPS of -$0.85 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement